Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom: Endauswertung
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis Electronic eBook |
| Language: | German |
| Published: |
2008
|
| Subjects: | |
| Online Access: | Volltext |
| Item Description: | Nebentitel: Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report |
| Physical Description: | 1 Online-Ressource (93 S.) graph. Darst. |
Staff View
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV026659133 | ||
| 003 | DE-604 | ||
| 005 | 20110228 | ||
| 006 | a m||| 00||| | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 110326s2008 |||| o||u| ||||||ger d | ||
| 035 | |a (OCoLC)918474978 | ||
| 035 | |a (DE-599)BVBBV026659133 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-578 | ||
| 100 | 1 | |a Gyllensvärd, Anne |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom |b Endauswertung |c vorgelegt von Anne Gyllensvärd, geb. Helm |
| 246 | 1 | 3 | |a Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report |
| 264 | 1 | |c 2008 | |
| 300 | |a 1 Online-Ressource (93 S.) |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Nebentitel: Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report | ||
| 502 | |a Berlin, Univ.-Medizin, Diss., 2008 | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 856 | 4 | 0 | |u http://www.diss.fu-berlin.de/2008/110/ |z lizenzfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-022208254 | ||
Record in the Search Index
| _version_ | 1804145266863898624 |
|---|---|
| any_adam_object | |
| author | Gyllensvärd, Anne |
| author_facet | Gyllensvärd, Anne |
| author_role | aut |
| author_sort | Gyllensvärd, Anne |
| author_variant | a g ag |
| building | Verbundindex |
| bvnumber | BV026659133 |
| collection | ebook |
| ctrlnum | (OCoLC)918474978 (DE-599)BVBBV026659133 |
| format | Thesis Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01407nmm a2200325 c 4500</leader><controlfield tag="001">BV026659133</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110228 </controlfield><controlfield tag="006">a m||| 00||| </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">110326s2008 |||| o||u| ||||||ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)918474978</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026659133</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gyllensvärd, Anne</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom</subfield><subfield code="b">Endauswertung</subfield><subfield code="c">vorgelegt von Anne Gyllensvärd, geb. Helm</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (93 S.)</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Nebentitel: Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Berlin, Univ.-Medizin, Diss., 2008</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.diss.fu-berlin.de/2008/110/</subfield><subfield code="z">lizenzfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022208254</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV026659133 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T23:16:44Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022208254 |
| oclc_num | 918474978 |
| open_access_boolean | |
| owner | DE-578 |
| owner_facet | DE-578 |
| physical | 1 Online-Ressource (93 S.) graph. Darst. |
| psigel | ebook |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| record_format | marc |
| spelling | Gyllensvärd, Anne Verfasser aut Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung vorgelegt von Anne Gyllensvärd, geb. Helm Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report 2008 1 Online-Ressource (93 S.) graph. Darst. txt rdacontent c rdamedia cr rdacarrier Nebentitel: Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report Berlin, Univ.-Medizin, Diss., 2008 (DE-588)4113937-9 Hochschulschrift gnd-content http://www.diss.fu-berlin.de/2008/110/ lizenzfrei Volltext |
| spellingShingle | Gyllensvärd, Anne Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung |
| subject_GND | (DE-588)4113937-9 |
| title | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung |
| title_alt | Phase III study - Gemcitabine, 5-FU and Folinic acid vs. Gemcitabine alone in the treatment of advanced, inoperable Pancreatic Carcinoma: final report |
| title_auth | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung |
| title_exact_search | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung |
| title_full | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung vorgelegt von Anne Gyllensvärd, geb. Helm |
| title_fullStr | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung vorgelegt von Anne Gyllensvärd, geb. Helm |
| title_full_unstemmed | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom Endauswertung vorgelegt von Anne Gyllensvärd, geb. Helm |
| title_short | Phase III Studie: Gemcitabin, 5-FU, Folinsäure vs. Gemcitabin allein in der Therapie des fortgeschrittenen, inoperablen Pankreaskarzinom |
| title_sort | phase iii studie gemcitabin 5 fu folinsaure vs gemcitabin allein in der therapie des fortgeschrittenen inoperablen pankreaskarzinom endauswertung |
| title_sub | Endauswertung |
| topic_facet | Hochschulschrift |
| url | http://www.diss.fu-berlin.de/2008/110/ |
| work_keys_str_mv | AT gyllensvardanne phaseiiistudiegemcitabin5fufolinsaurevsgemcitabinalleinindertherapiedesfortgeschritteneninoperablenpankreaskarzinomendauswertung AT gyllensvardanne phaseiiistudygemcitabine5fuandfolinicacidvsgemcitabinealoneinthetreatmentofadvancedinoperablepancreaticcarcinomafinalreport |